WHO Panel Recommends Against Use Of Remdesivir For COVID-19 Patients

>>Follow Matzav On Whatsapp!<<

A World Health Organization panel recommended against using remdesivir in hospitalized patients with COVID-19 because there is no evidence it improves survival.

The recommendation breaks with the Trump administration, as remdesivir recently became the only drug approved by the Food and Drug Administration to treat hospitalized COVID-19 patients.

The WHO panel also found the drug, which is delivered intravenously, had no real impact on whether patients would need to be put on ventilators.

Read more at The Hill.



  1. Very surprising that the truth about Remdemsivir should come from the Hill Fake News media. It is indeed mostly garbage, ineffective with many side effects. Hydroxychloroquine is much cheaper and a great treatment for most patients which is why Israel refuses to bring in hydroxychloroquine and sticks with Remdemsivir. Shameful!


Please enter your comment!
Please enter your name here